Clinical Impact Of Tp53 And Kmt2D Mutations In Mcl Receiving High-Dose Therapy And Autologous Transplantation: Updated Results From The Fondazione Italiana Linfomi Mcl0208 Phase Iii Trial
AuthID
P-00P-DX8
P-00P-DX8